Cancer, Bladder Completed Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Bladder Cancers / Bladder Cancer / Malignant neoplasm of urinary bladder NOS / Bladder neoplasms malignant / Malignant neoplasm of bladder / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0092003 (Cancer, Bladder)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02665039A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal FunctionTreatment
NCT01589094Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder CancerTreatment
NCT01191892Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerTreatment
NCT01089088Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)Treatment
NCT00310011Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the UrotheliumTreatment
NCT00055601Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder CancerTreatment
NCT00461851Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder CarcinomaTreatment
NCT00004223Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerTreatment
NCT00005086Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder CancerTreatment
NCT00006105Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder CancerTreatment
NCT00006351SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary TractTreatment
NCT00005644Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionTreatment
NCT00028860Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract CancerTreatment
NCT00045630S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumTreatment
NCT00055835S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumTreatment
NCT00053209Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumTreatment
NCT00089128Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder CancerTreatment
NCT00080795Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the UrotheliumTreatment
NCT00136175Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the BladderTreatment
NCT00234039S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-GuerinTreatment
NCT00234494Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell CancerTreatment
NCT00246974Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCTTreatment
NCT00268450Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By SurgeryTreatment
NCT00490880Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder CancerTreatment
NCT00585689Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder CancerTreatment
NCT00645593Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial CancerTreatment
NCT00847015Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerTreatment
NCT01697306The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer